{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T06:42:43Z","timestamp":1778481763991,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030009"],"award-info":[{"award-number":["82030009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejphar.2023.176011","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T04:31:50Z","timestamp":1692937910000},"page":"176011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["TCH-165 attenuates cardiac ischaemia\/reperfusion injury by balancing mitochondrial dynamics via increasing proteasome activity"],"prefix":"10.1016","volume":"957","author":[{"given":"Jing","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Xiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Na","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5983-4016","authenticated-orcid":false,"given":"Hui-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.176011_bib1","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200390","article-title":"Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy","volume":"11","author":"Aliabadi","year":"2021","journal-title":"Open Biol."},{"key":"10.1016\/j.ejphar.2023.176011_bib2","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2741\/4027","article-title":"Immune and non-immune functions of the immunoproteasome","volume":"17","author":"Angeles","year":"2012","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.ejphar.2023.176011_bib3","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1021\/jm400235r","article-title":"Inhibition of the human proteasome by imidazoline scaffolds","volume":"56","author":"Azevedo","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176011_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3390\/biom4030862","article-title":"Regulating the 20S proteasome ubiquitin-independent degradation pathway","volume":"4","author":"Ben-Nissan","year":"2014","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2023.176011_bib5","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1096\/fj.08-105940","article-title":"Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency","volume":"22","author":"Cai","year":"2008","journal-title":"FASEB. J."},{"key":"10.1016\/j.ejphar.2023.176011_bib6","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1038\/emm.2014.36","article-title":"CDK5-dependent inhibitory phosphorylation of Drp1 during neuronal maturation","volume":"46","author":"Cho","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2023.176011_bib7","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.257808","article-title":"MITOL-mediated DRP1 ubiquitylation and degradation promotes mitochondrial hyperfusion in a CMT2A-linked MFN2 mutant","volume":"135","author":"Das","year":"2022","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2023.176011_bib8","doi-asserted-by":"crossref","first-page":"14503","DOI":"10.1073\/pnas.0803998105","article-title":"The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and\/or inhibit fusion in Drosophila","volume":"105","author":"Deng","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2023.176011_bib9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cardiores.2003.12.023","article-title":"Role of apoptosis in reperfusion injury","volume":"61","author":"Eefting","year":"2004","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2023.176011_bib10","first-page":"579","article-title":"Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions","volume":"97","author":"Forte","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejphar.2023.176011_bib11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/s41419-018-1019-6","article-title":"HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer","volume":"9","author":"Huang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2023.176011_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5543452","article-title":"The role of mitochondrial quality control in cardiac ischemia\/reperfusion injury","volume":"2021","author":"Huang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176011_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41401-020-00518-y","article-title":"Drp1-dependent mitochondrial fission in cardiovascular disease","volume":"42","author":"Jin","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.176011_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.200611064","article-title":"The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division","volume":"178","author":"Karbowski","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejphar.2023.176011_bib15","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10787-021-00863-2","article-title":"Bortezomib: a proteasome inhibitor for the treatment of autoimmune diseases","volume":"29","author":"Khalesi","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2023.176011_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010054","article-title":"Site-specific proteasome inhibitors","volume":"12","author":"Kisselev","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejphar.2023.176011_bib17","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.4049\/jimmunol.1800197","article-title":"Ablation and inhibition of the immunoproteasome catalytic subunit LMP7 attenuate experimental abdominal aortic aneurysm formation in mice","volume":"202","author":"Li","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2023.176011_bib18","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1172\/JCI45709","article-title":"Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia\/reperfusion injury in mice","volume":"121","author":"Li","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2023.176011_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.117.10390","article-title":"Novel role for the immunoproteasome subunit PSMB10 in angiotensin II-induced atrial fibrillation in mice","volume":"71","author":"Li","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2023.176011_bib20","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/HYPERTENSIONAHA.118.11813","article-title":"Immunoproteasome subunit beta5i promotes ang II (angiotensin II)-Induced atrial fibrillation by targeting ATRAP (ang II type I receptor-associated protein) degradation in mice","volume":"73","author":"Li","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2023.176011_bib21","doi-asserted-by":"crossref","first-page":"22938","DOI":"10.1074\/jbc.M109.035774","article-title":"Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation","volume":"284","author":"Lutz","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176011_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137320","article-title":"I2-Imidazoline ligand CR4056 improves memory, increases ApoE expression and reduces BBB leakage in 5xFAD mice","volume":"23","author":"Mota","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176011_bib23","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1021\/acs.biochem.8b00579","article-title":"Small molecule modulation of proteasome assembly","volume":"57","author":"Njomen","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejphar.2023.176011_bib24","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1021\/acs.jmedchem.9b00101","article-title":"Proteasome activation as a new therapeutic approach to target proteotoxic disorders","volume":"62","author":"Njomen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2023.176011_bib25","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chembiol.2019.07.002","article-title":"Regulation of autophagic flux by the 20S proteasome","volume":"26","author":"Njomen","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ejphar.2023.176011_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10050938","article-title":"Small molecule 20S proteasome enhancer regulates MYC protein stability and exhibits antitumor activity in multiple myeloma","volume":"10","author":"Njomen","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejphar.2023.176011_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102706","article-title":"MK-886 protects against cardiac ischaemia\/reperfusion injury by activating proteasome-Keap1-NRF2 signalling","volume":"62","author":"Shi","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2023.176011_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911934","article-title":"PINK1 phosphorylates Drp1(S616) to improve mitochondrial fission and inhibit the progression of hypertension-induced HFpEF","volume":"23","author":"Shou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2023.176011_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8474303","article-title":"Parkin protects against oxygen-glucose deprivation\/reperfusion insult by promoting Drp1 degradation","volume":"2016","author":"Tang","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176011_bib30","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/CIRCRESAHA.112.270983","article-title":"Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice","volume":"111","author":"Tian","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.176011_bib31","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M110.144238","article-title":"Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in Parkinson disease","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.176011_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ymthe.2019.09.025","article-title":"Ablation of immunoproteasome beta5i subunit suppresses hypertensive retinopathy by blocking ATRAP degradation in mice","volume":"28","author":"Wang","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejphar.2023.176011_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6614009","article-title":"Role of oxidative stress in reperfusion following myocardial ischemia and its treatments","volume":"2021","author":"Xiang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176011_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau0495","article-title":"The immunoproteasome catalytic \u03b25i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation","volume":"5","author":"Xie","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2023.176011_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/nu15041049","article-title":"Ursolic acid ameliorates myocardial ischaemia\/reperfusion injury by improving mitochondrial function via immunoproteasome-PP2A-AMPK signalling","volume":"15","author":"Xu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2023.176011_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13189","article-title":"CaMKII induces permeability transition through Drp1 phosphorylation during chronic beta-AR stimulation","volume":"7","author":"Xu","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.176011_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2017.05.011","article-title":"Knockout of immunoproteasome subunit beta2i ameliorates cardiac fibrosis and inflammation in DOCA\/Salt hypertensive mice","volume":"490","author":"Yan","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.176011_bib38","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3389\/fphar.2018.01080","article-title":"Inhibition of ubiquitin-specific proteases as a novel anticancer therapeutic strategy","volume":"9","author":"Yuan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.176011_bib39","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2014.09.144","article-title":"Cdk1, PKCdelta and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death","volume":"453","author":"Zaja","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2023.176011_bib40","article-title":"Blockage of fibronectin 1 ameliorates myocardial ischemia\/reperfusion injury in association with activation of AMP-LKB1-AMPK signaling pathway","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2023.176011_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1159\/000518879","article-title":"Myocardial ischemia-reperfusion injury: therapeutics from a mitochondria-centric perspective","volume":"146","author":"Zhou","year":"2021","journal-title":"Cardiology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300523X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992300523X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:23:24Z","timestamp":1757978604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992300523X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":41,"alternative-id":["S001429992300523X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176011","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TCH-165 attenuates cardiac ischaemia\/reperfusion injury by balancing mitochondrial dynamics via increasing proteasome activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.176011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"176011"}}